Box | Folder
|
Title
|
|
LID Lab Research Reports,
1960-2004 [subseries]:
|
33 |
14-27 |
Clinical research projects,
1960-1982
|
33 |
28 |
NIAID ad hoc contract review,
1973
|
33 |
29 |
Experimental immunoprophylaxis against respiratory syncytial virus infections in primates,
undated
|
33 |
30 |
Experimental infection of primates with respiratory syncytial virus,
undated
|
33 |
31 |
Histological and virological study of the neurovirulence in rhesus monkeys of a langat/dengue 4 chimeric virus and its parental strains langat virus and dengue type 4 virus,
undated
|
33 |
32 |
Virological analyses of recombinant, live, attenuated respiratory syncytial virus subgroup A strain rA2cp248/404/1030ΔSH in healthy unscreened 4-12 weeks old infants,
undated
|
33 |
33 |
RNA tumor viruses as etiologic agents of solid tumors as well as leukemia - NIAID/NCI collaborative research,
1968
|
33 |
34 |
Determination of the effect of an inducer of interferon (IN-CN) administered to upper respiratory tract on experimentally induced respiratory virus infections,
1969
|
33 |
35 |
Safety of cold adapted respiratory syncytial virus vaccine in infants 6-7 months of age,
1969
|
33 |
36 |
Serum complement in acute bronchiolitis,
1969
|
33 |
37 |
Pediatric adenovirus vaccine evaluations,
1971
|
33 |
38 |
Fort Detrick reports,
1972-1977
|
34 |
1 |
Chanock scientific studies,
1973-1992
|
34 |
2 |
Transferring viruses to NIAID,
1997-1998
|
34 |
3 |
Development of a rotavirus vaccine for the prevention of severe rotavirus diarrhea of infants and young children - LID Epidemiology section,
c.2000
|
34 |
4-5 |
Development of new approaches for vaccines against the tick-borne encephalitis virus complex - Molecular Viral Biology section,
2000-2001
|
34 |
6 |
Phase I study of Ad4-ΔE3-HIVenv and Ad4-ΔE3-HIV/gag/pro recombinant vaccines in HIV-negative volunteers,
2001
|
34 |
7 |
Projected schedule for WNV/DEN4 chimera studies,
2001
|
34 |
8 |
New molecular approaches to develop live attenuated vaccines against the tick-borne encephalitis complex and the West Nile encephalitis virus,
2003
|
34 |
9 |
The development of vaccines for parainfluenza virus types 1, 2, and 3 - Respiratory Viruses section,
2004
|
34 |
10 |
In vitro models of paramyxovirus infection,
2004
|
34 |
11 |
New molecular approaches to develop live attenuated vaccines against tick-borne encephalitis virus complex and the West Nile and St. Louis encephalitis viruses - Respiratory Viruses section,
2004
|
34 |
12 |
NIAID 69-A - Study of non-bacterial respiratory disease A) children,
1966-1969
|
34 |
13 |
NIAID 69-B - Non-bacterial respiratory disease in military recruits - epidemiology and experimental immunoprophylaxis,
1966
|
34 |
14 |
NIAID 69-C - The etiology of acute respiratory disease in civilian adults,
1965
|
34 |
15 |
NIAID 69-D - Collaborative studies of biophysical properties of respiratory viruses which are important to the development of vaccines,
1966
|
34 |
16 |
NIAID 70-A - Laboratory studies of newly r4ecognized viruses associated with respiratory illness,
1966
|
34 |
17 |
NIAID 70-B - Characterization of newly discovered rhinovirus serotypes of human origin,
1966
|
34 |
18 |
NIAID 70-C - Basic studies on mycoplasma,
1966
|
34 |
19 |
NIAID 70-C.1 - Serology and seroepidemiology of mycoplasmas (pleuropneumonia-like organisms - PPLO),
1966
|
34 |
20 |
NIAID 70-D - Laboratory studies of viral hepatitis agents,
1966
|
34 |
21 |
NIAID 70-E - Biological and biophysical studies of rhinoviruses,
1966-1969
|
34 |
22 |
NIAID 72-B - Study of respiratory viruses and mycoplasmas in human volunteers,
1969
|